RESUMO
Aim/Introduction: This investigation aimed to clarify the relationship between cognitive function and blood glucose control in the elderly individuals with type 1 diabetes. Materials and methods: In total, 45 patients with type 1 diabetes, age 74.9 ± 6.7 years, and HbA1c levels of 7.9 ± 0.9% were studied. Severe hypoglycemia occurred in 33% of patients, and the number of severe hypoglycemia episodes was 0.6 ± 1.2 in the past 5 years before the time of the cognitive function tests. We analyzed clinical data and dementia scores on the Revised Hasegawa's Dementia Scale (HDS-R), Mini-Mental State Examination (MMSE), and Dementia Assessment Sheet for Community-based Integrated Care System, and 21 items (DASC-21). Results: There was a significant correlation between HbA1c and HDS-R, MMSE, respectively. There was a significant correlation between the number of severe hypoglycemic episodes and HDS-R, MMSE, and DASC-21, respectively. When the group with experience of severe hypoglycemia was compared to the control group, HDS-R, MMSE, and DASC-21 were meaningfully different after adjusting for age modeling analysis of covariance. Conclusions: In elderly individuals with type 1 diabetes, our results suggest that high HbA1c for the past 5 years from the cognitive function test and a history of severe hypoglycemic episodes from the time of disease diagnosis are related to decreased cognitive function.
RESUMO
(1) Background: Arteriosclerosis is associated with high levels of low-density lipoprotein (LDL) cholesterol. O-methylated catechins in "Benifuuki" green tea are expected to reduce cholesterol levels, although there is limited research regarding this topic; (2) Methods: This trial evaluated 159 healthy volunteers who were randomized to receive ice cream containing a high-dose of "Benifuuki" extract including 676 mg of catechins (group H), a low-dose of "Benifuuki" extract including 322 mg of catechins (group L), or no "Benifuuki" extract (group C). Each group consumed ice cream (with or without extract) daily for 12 weeks, and their lipid-related parameters were compared; (3) Results: A significant reduction in the level of lectin-like oxidized LDL receptor-1 ligand containing ApoB (LAB) was detected in group H, compared to groups L and C. No significant differences between the three groups were detected in their levels of total cholesterol, triglycerides, and LDL cholesterol; (4) Conclusions: "Benifuuki" extract containing O-methylated catechins may help prevent arteriosclerosis.
Assuntos
Apolipoproteína B-100/antagonistas & inibidores , Camellia sinensis/química , Suplementos Nutricionais , Hiperlipidemias/prevenção & controle , Hipolipemiantes/administração & dosagem , Extratos Vegetais/administração & dosagem , Receptores Depuradores Classe E/metabolismo , Idoso , Apolipoproteína B-100/sangue , Biomarcadores/sangue , Catecóis/administração & dosagem , Catecóis/uso terapêutico , Método Duplo-Cego , Feminino , Manipulação de Alimentos , Preferências Alimentares , Humanos , Hiperlipidemias/sangue , Hipolipemiantes/uso terapêutico , Sorvetes , Análise de Intenção de Tratamento , Japão , Ligantes , Masculino , Pessoa de Meia-Idade , Oxirredução , Extratos Vegetais/uso terapêutico , Folhas de Planta/químicaRESUMO
OBJECTIVE: A reduction in endothelial progenitor cell (EPC) count is considered to correlate with cumulative cardiovascular risk factors including hyperglycemia. This study was conducted to elucidate the influence of glycemic variability on EPC count in patients with diabetes. METHODS: In study 1, we examined the number of EPCs in 57 patients with type 1 diabetes and 43 patients with type 2 diabetes. The number of EPCs (CD34+, CD34+CD133+, CD34+CD309+, and CD34+CD133+CD309+) was counted as the number of cells per 106 events. In study 2, we examined 37 outpatients with type 1 diabetes without macrovascular complications. We assessed associations between EPC count and seven parameters of glycemic variability (blood glucose standard deviation, mean amplitude of glycemic excursion, J index, M value, mean of daily differences, low blood glucose index, and high blood glucose index), as measured by continuous glucose monitoring. We further analyzed the correlation between EPC count and the carotid intima-media thickness (IMT) in 24 patients. RESULTS: In study 1, the number of circulating CD34+ and CD34+CD133+ cells was significantly decreased in patients with type 1 diabetes relative to that in patients with type 2 diabetes (p = 0.020 and 0.036, respectively). In study 2, a univariate analysis showed that the J index was negatively correlated with logCD34+ (r = -0.342, p = 0.039). LogCD34+ was significantly negatively associated with the max IMT (r = -0.486, p = 0.012) and the mean IMT (r = -0.503, p = 0.016). CONCLUSIONS: An increase in the J index, which reflects both hyperglycemia and glycemic variability, is associated with a reduction in the EPC count, which might result in the progression of diabetic vascular complications.
RESUMO
AIMS/HYPOTHESIS: Fulminant type 1 diabetes (FT1D) is a distinct subtype of type 1 diabetes and is fatal without immediate diagnosis and treatment. At present, there are no biomarkers for early and predictive detection of FT1D. METHODS: First, we analyzed a total of 6 serum samples from 3 patients with FT1D (1 sample in the acute and 1 in the sub-acute phases from each patient) by seromic analysis. Second, titres of the antibody were measured by ELISA in sera from 30 patients with FT1D (both in the acute and sub-acute phases), 13 patients with FT1D in the chronic phase, 32 patients with autoimmune type 1 (type 1A) diabetes (T1AD), 30 patients with type 2 diabetes (T2D), 23 patients with autoimmune thyroid disease (AITD) and 31 healthy control subjects (HC). RESULTS: Seromic analysis revealed 9 antibodies which showed high signals from all 3 patients with FT1D in the acute phase. Among them, the titre of anti-CD300e antibody was significantly higher in FT1D patients in the acute phase than that in T1AD, T2D, AITD patients and HC, as determined by ELISA (P<0.01, respectively). The titre of anti-CD300e antibody was also higher in FT1D in the acute phase than that in the sub-acute phase (P = 0.0018, Wilcoxon signed-rank test). The titre of anti-LGALS3 antibody in FT1D patients in the acute phase did not differ from that in patients with FT1D in the sub-acute phase, T1AD, T2D, AITD and HC. CONCLUSION/INTERPRETATION: The titre of a novel antibody, anti-CD300e, was high in sera from patients with FT1D. This antibody might be a diagnostic marker and provide new insight into the pathogenesis of FT1D.
Assuntos
Antígenos de Superfície/imunologia , Autoanticorpos/sangue , Biomarcadores/sangue , Diabetes Mellitus Tipo 1/diagnóstico , Glicoproteínas de Membrana/imunologia , Adulto , Diabetes Mellitus Tipo 1/sangue , Ensaio de Imunoadsorção Enzimática , Feminino , Citometria de Fluxo , Células HEK293 , Humanos , Masculino , Pessoa de Meia-Idade , Curva ROCRESUMO
We tested the validity of instructing patients to minimally contract the muscle to facilitate F-wave recording in clinical practice. In 12 healthy subjects, F waves were recorded from the first dorsal interosseous muscle at rest, during motor imagery, and at up to 30% of the maximal voluntary contraction (MVC). F-wave persistence increased significantly from 32.5 +/- 11.9% (mean +/- SD) at rest to 58.3 +/- 15.2% during motor imagery and 90.0 +/- 8.7% during 3% MVC. It then remained the same during stepwise changes to and from 30% MVC before decreasing significantly from 80.8 +/- 18.5% during 3% MVC to 48.7 +/- 23.8% during motor imagery and 27.0 +/- 16.0% at rest. The trial average of F-wave amplitude showed a similar pattern of facilitation. Motor imagery enhances F-wave persistence and amplitude, which further increase with a slight muscle contraction and show no additional change with a stronger effort.
Assuntos
Potenciais de Ação/fisiologia , Imaginação/fisiologia , Contração Muscular/fisiologia , Músculo Esquelético/fisiologia , Adolescente , Adulto , Análise de Variância , Estimulação Elétrica , Eletromiografia , Potencial Evocado Motor/fisiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Destreza Motora/fisiologiaRESUMO
To investigate how the sleep affects the recovery functions of somatosensory evoked potential, we studied somatosensory evoked potential recovery functions of the median nerve during awake to sleep in eight healthy adults, using the paired conditioning and test stimulus paradigm. The most notable difference between wakefulness and sleep was the much greater enhancement of parietal P26 and frontal P22 in sleep than in awake state at interstimulus intervals of 20 to 100 milliseconds of paired stimulus paradigm. Although the enhanced P26 and P22 were observed in control somatosensory evoked potential during sleep, the augmentation was much greater when conditioned by preceding stimulus. In contrast, the parietal P40-N60 and frontal fP40-fN60 of test response were more depressed in sleep than in wakefulness. As a whole, the recovery curves in sleep appeared to be shifted to the right as compared with those in the awake, suggesting delayed recovery function in sleep. The augmentation of frontal P22 and parietal P26 in sleep, contrasting depressed other components, most notably fP40-fN60 and parietal P40-N60, imply that the former components reflect inhibitory and the latter to the excitatory process. This is the first study that demonstrates the somatosensory evoked potential recovery functions are different from those of awake state.
Assuntos
Potenciais Somatossensoriais Evocados/fisiologia , Nervo Mediano/fisiologia , Recuperação de Função Fisiológica/fisiologia , Sono/fisiologia , Córtex Somatossensorial/fisiologia , Vigília/fisiologia , Adaptação Fisiológica/fisiologia , Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Adulto JovemRESUMO
PURPOSE: To determine possible hemispheric differences of motor imagery in facilitating the anterior horn cells. METHODS: We conducted a side-to-side comparison of motor imagery to counter rest-induced suppression of spinal motor neurons in 10 right-handed healthy adults using the F wave as a measure of excitability. Studies consisted of sequential recording of F waves from the abductor pollicis brevis with 100 supramaximal stimuli applied to the median nerve on three consecutive sessions: (1) after standardized hand exercise to establish the baseline; (2) after immobilizing abductor pollicis brevis bilaterally for 3 hours, with one side assigned to relaxation task and the other side to motor imagery task; and (3) after standardized hand exercise to assess a recovery. The same sequence was repeated, switching the side of relaxation and motor imagery tasks. RESULTS: F-wave persistence and average amplitude showed a significant decrease (P < 0.01) from baseline after relaxation task, recovering quickly after exercise, but no change (P > 0.05) after motor imagery task. The results showed no significant differences (P > 0.05) between dominant and nondominant hands. CONCLUSION: Motor imagery facilitates the spinal motor neurons without hemispheric asymmetry.
Assuntos
Lateralidade Funcional , Imaginação/fisiologia , Atividade Motora , Neurônios Motores/fisiologia , Medula Espinal/fisiologia , Adulto , Estimulação Elétrica , Eletromiografia , Feminino , Mãos/fisiologia , Humanos , Masculino , Nervo Mediano/fisiologia , Pessoa de Meia-Idade , Músculo Esquelético/fisiologia , Projetos Piloto , Relaxamento/fisiologia , Adulto JovemRESUMO
(-)-1-(3,4-Dimethoxyphenetylamino)-3-(3,4-dihydroxy)-2-propanol [(-)-RO363] is a highly selective beta(1)-adrenergic receptor (beta(1)AR) agonist. To study the binding site of beta(1)-selective agonist, chimeric beta(1)/beta(2)ARs and Ala-substituted beta(1)ARs were constructed. Several key residues of beta(1)AR [Leu(110) and Thr(117) in transmembrane domain (TMD) 2], and Phe(359) in TMD 7] were found to be responsible for beta(1)-selective binding of (-)-RO363, as determined by competitive binding. Based on these results, we built a three-dimensional model of the binding domain for (-)-RO363. The model indicated that TMD 2 and TMD 7 of beta(1)AR form a binding pocket; the methoxyphenyl group of N-substituent of (-)-RO363 seems to locate within the cavity surrounded by Leu(110), Thr(117), and Phe(359). The amino acids Leu(110) and Phe(359) interact with the phenyl ring of (-)-RO363, whereas Thr(117) forms hydrogen bond with the methoxy group of (-)-RO363. To examine the interaction of these residues with beta(1)AR in an active state, each of the amino acids was changed to Ala in a constitutively active (CA)-beta(1)AR mutant. The degree of decrease in the affinity of CA-beta(1)AR for (-)-RO363 was essentially the same as that of wild-type beta(1)AR when mutated at Leu(110) and Thr(117). However, the affinity was decreased in Ala-substituted mutant of Phe(359) compared with that of wild-type beta(1)AR. These results indicated that Leu(110) and Thr(117) are necessary for the initial binding of (-)-RO363 with beta(1)-selectivity, and interaction of Phe(359) with the N-substituent of (-)-RO363 in an active state is stronger than in the resting state.